Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator Era

Co PIs Drs. Chris Goss, professor (Pulmonary, Critical Care and Sleep Medicine) and Luke Hoffman (Pediatrics) have received a five-year renewal for their cystic fibrosis-focused program project grant entitled, “Center for CF Translational Research in the Post-CFTR modulator Era.”

The University of Washington Cystic Fibrosis (CF) Research and Translational Core Center (CFRTC) focuses its research on developing new and improved treatments for patients with Cystic Fibrosis and understanding the impact of these new therapies on patient health.

The Center has a long history of strong partnerships between laboratory and clinically based scientists working together to take observations from the laboratory and transforming these findings into better therapies to treat the nutritional, digestive, metabolic, kidney and systemic aspects of CF.

The CFRTC has 3 biomedical cores (Genomic and Genomic Analysis Core, Biostatistics and Informatics Core, and Clinical and Specimen Core), a pilot and feasibility program, an Administrative Core and enrichment programs to encourage research collaborations.